Azenta Inc (NAS:AZTA)
$ 46.21 -0.9 (-1.91%) Market Cap: 2.11 Bil Enterprise Value: 1.70 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 74/100

Azenta Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 06:55PM GMT
Release Date Price: $50.82 (+0.32%)
Unidentified Analyst

Hi. Good afternoon. I'm Fernando Marin, Executive Director in the Life Sciences Tools and Diagnostics coverage team at Morgan Stanley. Before we begin, I'd like to remind you that important disclosure information can be found at the Morgan Stanley research disclosure website. If you have any questions, flitch out to your Morgan Stanley sales representative.

With that, it's my pleasure to hold Azenta today. Speaking on behalf of the company is CFO, Lindon Robertson. Lindon, thanks for joining us today.

Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO

It's our pleasure. Thank you for having us.

Questions & Answers

Unidentified Analyst

And to start, maybe can you just provide the audience with a brief overview of the company's recent trajectory and key accomplishments and opportunities going forward?

Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO

Yes, really happy to. Azenta is a business that's really focused on sample-based

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot